REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanghai Micurx Pharmaceutical Co., Ltd. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) is based in China. The head office is in Shanghai. It operates in the Pharmaceutical and Medicine Manufacturing industry. Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) was incorporated on August 07, 2012. 179 (2022) employees currently work for Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司). There was a net sales revenue increase of 8.83% reported in Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司)’s latest financial highlights for 2025. Its’ total assets recorded a negative growth of 16.96%. The enterprise’s net profit margin increased by 167.89% in 2025.

Headquarters
Building 101, 2, 1-4 Floor, No. 53 Edison Road, China (Shanghai) Pilot Free Trade Zone, Shanghai
Shanghai; Shanghai; Postal Code: 201210

Contact Details: Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.

Website: http://micurxchina.com

Basic Information
Total Employees:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.
Registered Capital:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report to view the information.
Incorporation Date:
August 07, 2012
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
10.92%
Purchase this report to view the information.
10.8%
Purchase this report to view the information.
10.49%
Purchase this report to view the information.
5.89%
Purchase this report to view the information.
3.47%
Subsidiaries
Corecase (Beijing) Pharmaceutical Co., Ltd.
Mengke Pharmaceutical Technology (Shanghai) Co., Ltd.
Micurx Pharmaceuticals, Inc.
Company Performance
Financial values in the chart are available after Shanghai Micurx Pharmaceutical Co., Ltd. (上海盟科药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
8.83%
Total Operating Revenue
0.62%
Operating Profit
43.59%
Net Profit/Loss for the Period
45.18%
Total Assets
-16.96%
Total Equity
-53.18%
Operating Profit Margin
160.66%
Net Profit Margin
167.89%
Return on Equity (ROE)
-17.15%
Debt / Equity
86674%
Quick Ratio
-726.98%
Cash Ratio
-0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?